Clinical trial

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

NCT00423475

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record goserelin acetate Normalized identity: goserelin acetateView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention adjuvant therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-10-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

goserelin acetateDRUG · verified · RxNorm: goserelin acetate

adjuvant therapyPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

UNICANCERlead sponsor

AstraZenecacollaborator

Mapped research locations

ParisFrance4 ToulouseFrance1 MarseilleFrance1 MontpellierFrance1 LyonFrance1 LilleFrance1 BordeauxFrance1 RennesFrance1 NiceFrance1 CaenFrance1 AngersFrance1 BesançonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00423475 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.